Virology News and Research

Latest Virology News and Research

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.

12 Jan 2010

Phase I clinical trial of XRX-001 for yellow fever initiated

Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.

12 Jan 2010

Life Technologies to acquire AcroMetrix

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount.

12 Jan 2010

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides, Inc. (the "Company"), reports that the Company has been invited to present on January 12th at the Biotech Showcase™, a conference designed to showcase promising companies and technologies for partnering and investment purposes.

12 Jan 2010

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company’s increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.

12 Jan 2010

New findings would allow doctors to tailor drug cocktails for particular viral strains

Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.

12 Jan 2010

Millipore introduces new Viresolve Pro+ Solution

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced the availability of its new Viresolve® Pro+ Solution, an innovative virus filtration product that further extends the company’s leadership in the rapidly growing and highly regulated virus safety market.

12 Jan 2010

American Red Cross urges Americans to get vaccinated against H1N1 virus

The H1N1 (swine) flu virus is still prevalent across the nation, and the American Red Cross encourages everyone to get vaccinated against the virus, now that the vaccine is widely available.

12 Jan 2010

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

Inhibitex, Inc. today announced that its collaborator, Pfizer, Inc., has initiated patient recruitment for 408-patient, randomized, double-blind Phase I clinical trial to evaluate the safety, tolerability, and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus (S. aureus) vaccine (SA3Ag) in healthy adults.

12 Jan 2010

Yoga lowers number of compounds in blood and reduces inflammation

Regularly practicing yoga exercises may lower a number of compounds in the blood and reduce the level of inflammation that normally rises because of both normal aging and stress, a new study has shown.

12 Jan 2010

U.S. changes HIV policy to allow foreigners with virus to enter

Los Angeles Times: "Last Monday, for the first time in 22 years, foreigners with HIV were legally allowed to enter the United States without their infection status being considered. Before that, even short-term visitors had to receive special permission — or lie on their visa application — to come here.

12 Jan 2010

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

Stepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign similar to the effort that dispelled the stigma of HIV/AIDS are needed to curb the health threats posed by hepatitis B and hepatitis C, says a new report from the Institute of Medicine.

12 Jan 2010

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) National Influenza Vaccination Week (NIVW), January 10-16, 2010, which highlights the importance of annual influenza vaccination after the holiday season into January and beyond.

12 Jan 2010

Official H1N1-related death count approaches 13,000 worldwide, WHO says

H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).

12 Jan 2010

Cancer drug may provide an effective secondary treatment for gut tumor

A drug that is already an approved therapy for some cancers also might be an effective secondary treatment for a rare tumor of the gastrointestinal tract, according to a team led by researchers from the University of Pittsburgh Cancer Institute (UPCI). The findings, based on experiments using cell cultures, were published in the Jan. 1 issue of Cancer Research.

12 Jan 2010

Vertex Pharmaceuticals plans proof-of-concept clinical trials in RA and epilepsy

Vertex Pharmaceuticals Incorporated today provided an update on key 2010 business priorities in conjunction with the 28th Annual J.P. Morgan Healthcare Conference in San Francisco. The company also discussed recent progress in its lead development programs in hepatitis C virus (HCV) infection and cystic fibrosis (CF) and outlined proof-of-concept clinical trials planned in other serious diseases for 2010.

11 Jan 2010

Virology News and Research

Latest Virology News and Research

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

Phase I clinical trial of XRX-001 for yellow fever initiated

Life Technologies to acquire AcroMetrix

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

New findings would allow doctors to tailor drug cocktails for particular viral strains

Millipore introduces new Viresolve Pro+ Solution

American Red Cross urges Americans to get vaccinated against H1N1 virus

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

Yoga lowers number of compounds in blood and reduces inflammation

U.S. changes HIV policy to allow foreigners with virus to enter

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

Official H1N1-related death count approaches 13,000 worldwide, WHO says

Cancer drug may provide an effective secondary treatment for gut tumor

Vertex Pharmaceuticals plans proof-of-concept clinical trials in RA and epilepsy

Highmark joins with CDC to promote National Influenza Vaccination Week

Gene therapy may help correct molecular flaws that cause brain disease

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

R. Palmer Beasley awarded Hepatitis B Foundation's Distinguished Scientist Award 2010

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows